U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Topical Dermatologic Corticosteroids: in Vivo Bioequivalence
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Topical Dermatologic Corticosteroids: in Vivo Bioequivalence June 1995

Download the Final Guidance Document
Final
Docket Number:
FDA-2021-D-0384
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guidance provides recommendations to pharmaceutical sponsors on methods to document in vivo bioequivalence of topical dermatologic corticosteroids, hereinafter referred to as topical corticosteroids.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2021-D-0384.

 
Back to Top